582 related articles for article (PubMed ID: 18353489)
21. Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin.
Deng G; Curriden SA; Hu G; Czekay RP; Loskutoff DJ
J Cell Physiol; 2001 Oct; 189(1):23-33. PubMed ID: 11573201
[TBL] [Abstract][Full Text] [Related]
22. Plasminogen activator inhibitor type 1 promotes fibrosarcoma cell migration by modifying cellular attachment to vitronectin via alpha(v)beta(5) integrin.
Takahashi T; Suzuki K; Ihara H; Mogami H; Kazui T; Urano T
Semin Thromb Hemost; 2005 Jun; 31(3):356-63. PubMed ID: 16052409
[TBL] [Abstract][Full Text] [Related]
23. High-molecular-weight serum protein complexes differentially promote cell migration and the focal adhesion localization of the urokinase receptor in human glioma cells.
Hedberg KK; Stauff C; Høyer-Hansen G; Rønne E; Griffith OH
Exp Cell Res; 2000 May; 257(1):67-81. PubMed ID: 10854055
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion.
Elia C; Cassol E; Sidenius N; Blasi F; Castagna A; Poli G; Alfano M
J Leukoc Biol; 2007 Nov; 82(5):1212-20. PubMed ID: 17704294
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of integration of cells and extracellular matrices by integrins.
Humphries MJ; Travis MA; Clark K; Mould AP
Biochem Soc Trans; 2004 Nov; 32(Pt 5):822-5. PubMed ID: 15494024
[TBL] [Abstract][Full Text] [Related]
26. Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo.
van der Pluijm G; Sijmons B; Vloedgraven H; van der Bent C; Drijfhout JW; Verheijen J; Quax P; Karperien M; Papapoulos S; Löwik C
Am J Pathol; 2001 Sep; 159(3):971-82. PubMed ID: 11549590
[TBL] [Abstract][Full Text] [Related]
27. Urokinase receptor (CD87) clustering in detergent-insoluble adhesion patches leads to cell adhesion independently of integrins.
Petzinger J; Saltel F; Hersemeyer K; Daniel JM; Preissner KT; Wehrle-Haller B; Kanse SM
Cell Commun Adhes; 2007 Oct; 14(4):137-55. PubMed ID: 17957530
[TBL] [Abstract][Full Text] [Related]
28. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.
Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS
J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
[TBL] [Abstract][Full Text] [Related]
29. Promotion of leukocyte adhesion by a novel interaction between vitronectin and the beta2 integrin Mac-1 (alphaMbeta2, CD11b/CD18).
Kanse SM; Matz RL; Preissner KT; Peter K
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2251-6. PubMed ID: 15458976
[TBL] [Abstract][Full Text] [Related]
30. Cellular mechanisms regulating non-haemostatic plasmin generation.
Bass R; Ellis V
Biochem Soc Trans; 2002 Apr; 30(2):189-94. PubMed ID: 12023849
[TBL] [Abstract][Full Text] [Related]
31. Differential modulation of integrin expression in chondrocytes during expansion for tissue engineering.
Goessler UR; Bugert P; Bieback K; Huber K; Fleischer LI; Hormann K; Riedel F
In Vivo; 2005; 19(3):501-7. PubMed ID: 15875768
[TBL] [Abstract][Full Text] [Related]
32. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells.
Cao DJ; Guo YL; Colman RW
Circ Res; 2004 May; 94(9):1227-34. PubMed ID: 15044324
[TBL] [Abstract][Full Text] [Related]
33. Microglial expression of alphavbeta3 and alphavbeta5 integrins is regulated by cytokines and the extracellular matrix: beta5 integrin null microglia show no defects in adhesion or MMP-9 expression on vitronectin.
Milner R
Glia; 2009 May; 57(7):714-23. PubMed ID: 18985734
[TBL] [Abstract][Full Text] [Related]
34. Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiology.
Beattie J; McIntosh L; van der Walle CF
J Cell Physiol; 2010 Sep; 224(3):605-11. PubMed ID: 20432472
[TBL] [Abstract][Full Text] [Related]
35. Vitronectin inhibits plasminogen activator inhibitor-1-induced signalling and chemotaxis by blocking plasminogen activator inhibitor-1 binding to the low-density lipoprotein receptor-related protein.
Kamikubo Y; Neels JG; Degryse B
Int J Biochem Cell Biol; 2009 Mar; 41(3):578-85. PubMed ID: 18703159
[TBL] [Abstract][Full Text] [Related]
36. Assembly and signaling of adhesion complexes.
Sepulveda JL; Gkretsi V; Wu C
Curr Top Dev Biol; 2005; 68():183-225. PubMed ID: 16125000
[TBL] [Abstract][Full Text] [Related]
37. Podosome-type adhesions and focal adhesions, so alike yet so different.
Block MR; Badowski C; Millon-Fremillon A; Bouvard D; Bouin AP; Faurobert E; Gerber-Scokaert D; Planus E; Albiges-Rizo C
Eur J Cell Biol; 2008 Sep; 87(8-9):491-506. PubMed ID: 18417250
[TBL] [Abstract][Full Text] [Related]
38. Fibronectin promotes brain capillary endothelial cell survival and proliferation through alpha5beta1 and alphavbeta3 integrins via MAP kinase signalling.
Wang J; Milner R
J Neurochem; 2006 Jan; 96(1):148-59. PubMed ID: 16269008
[TBL] [Abstract][Full Text] [Related]
39. Integrin connections map: to infinity and beyond.
Martin KH; Slack JK; Boerner SA; Martin CC; Parsons JT
Science; 2002 May; 296(5573):1652-3. PubMed ID: 12040184
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of integrin-mediated adhesion and signaling disrupts retinal development.
Li M; Sakaguchi DS
Dev Biol; 2004 Nov; 275(1):202-14. PubMed ID: 15464583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
